Artificial Intelligence

A new FDA clearance for its AI software enhances Hyperfine's portable MRI, positioning it to disrupt the lucrative stroke diagnostics market. Here's why.

As Spruce Biosciences preps its rare disease drug for FDA review, the addition of a commercial veteran signals a high-stakes shift from R&D to market.

Beyond vaccines, Strand Therapeutics' programmable mRNA shows stunning success in late-stage cancer, heralding a new age of logic-driven genetic medicine.

The hiring of M&A veteran Eric Olson as Chief Corporate Development Officer signals REI Systems’ aggressive new strategy to conquer the national security market.

A new drug for a leading cause of blindness missed its primary goal, yet its unique ability to improve vision offers new hope for millions of patients.

Talen Energy unveils a major executive overhaul and a novel compensation plan, signaling a strategic pivot to dominate the energy-hungry AI data center market.

A public fund's major investment in Consensys, the firm behind MetaMask, signals growing institutional confidence in Web3's foundational infrastructure.

A pivotal trial success in lupus for BTK inhibitor orelabrutinib not only offers new hope for patients but also validates Zenas BioPharma's strategy.

The crypto giant reports massive growth, but a pivot to AI, operational fires, and rising debt reveal a risky strategy to reshape global computing power.

Beyond software, a new accelerator offers hardware startups a rare advantage, bridging the gap from university labs to investor-ready prototypes.

A new AI system deters birds to prevent avian flu. But its real innovation lies in data, transforming biosecurity from a costly chore into a profitable investment.

California's Movandi is moving to Riyadh. A look at how sovereign incentives are building a new semiconductor hub and the wireless backbone for an AI future.

Tech innovator Jay Walker is launching REVIVE, a media network aiming for 180M homes. This isn't just new content; it's a strategic play in the national information ecosystem.

Beyond the runway hype, AI is now a core driver of commerce. But does it level the playing field or just raise the stakes for everyone involved?

Beyond a simple date change for its $10M dividend, Dominari Holdings is signaling a major strategic shift, funded by investment gains and aimed at AI.

indie Semiconductor is aggressively using stock grants to lure top engineers for its ADAS future. But what is the cost of this talent war for investors?

As AI adoption surges, one firm's rigorous SOC 2 compliance offers a new blueprint for trust in an era of high-stakes data and complex cyber threats.

From biopharma to webcomics, shareholder lawsuits reveal the perils of misleading investors. A look at four companies facing legal and financial fallout.

HCIactive's SmartBenefits.ai promises AI-powered clarity for your health plan, but a major data breach reveals the high-stakes risks of this new frontier.

A sustainable energy firm eyes $75M in fees from a $300M Ripple Labs share deal in South Korea. Is this a genius, capital-light move into crypto?